Sinopharm Group Co Ltd
01099: XHKG (HKG)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
HK$64.60 | Rsnwj | Phqcscpn |
Sinopharm: Placing Coverage Under Review
We are placing coverage of narrow-moat-rated Sinopharm under review pending the transfer of coverage to a new analyst. We expect to revisit our coverage of this company over the next three months. Our most recent fair value estimate was HKD 29.50.